Abstract
The RAS pathway is among the most frequently activated signaling nodes in cancer. However, the mechanisms that alter RAS activity in human pathologies are not entirely understood. The most prevalent post-translational modification within the GTPase core domain of NRAS and KRAS is ubiquitination at lysine 128 (K128), which is significantly decreased in cancer samples compared to normal tissue. Here, we found that K128 ubiquitination creates an additional binding interface for RAS GTPase-activating proteins (GAPs), NF1 and RASA1, thus increasing RAS binding to GAP proteins and promoting GAP-mediated GTP hydrolysis. Stimulation of cultured cancer cells with growth factors or cytokines transiently induces K128 ubiquitination and restricts the extent of wild-type RAS activation in a GAP-dependent manner. In KRAS mutant cells, K128 ubiquitination limits tumor growth by restricting RAL/ TBK1 signaling and negatively regulating the autocrine circuit induced by mutant KRAS. Reduction of K128 ubiquitination activates both wild-type and mutant RAS signaling and elicits a senescence-associated secretory phenotype, promoting RAS-driven pancreatic tumorigenesis.
Original language | English |
---|---|
Pages (from-to) | 2862-2877 |
Number of pages | 16 |
Journal | EMBO Journal |
Volume | 43 |
Issue number | 14 |
DOIs | |
State | Published - 15 Jul 2024 |
Keywords
- NF1
- RAS Interactome
- RAS Signaling
- Senescence-Associated Secretory Phenotype
- Ubiquitination
All Science Journal Classification (ASJC) codes
- General Immunology and Microbiology
- General Biochemistry,Genetics and Molecular Biology
- Molecular Biology
- General Neuroscience